BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer.

Lochmann, Timothy L; Bouck, Ynes M; Faber, Anthony C

Lochmann, Timothy L; Bouck, Ynes M; Faber, Anthony C.

Afiliação

Lochmann TL; Anthony Faber: Philips Institute for Oral Health Research, Virginia Commonwealth University School of Dentistry and Massey Cancer Center, Richmond, VA, USA.
Bouck YM; Anthony Faber: Philips Institute for Oral Health Research, Virginia Commonwealth University School of Dentistry and Massey Cancer Center, Richmond, VA, USA.
Faber AC; Anthony Faber: Philips Institute for Oral Health Research, Virginia Commonwealth University School of Dentistry and Massey Cancer Center, Richmond, VA, USA.

Oncoscience ; 5(7-8): 218-219, 2018 Jul.

Article em En | MEDLINE | ID: mdl-30234143

Palavras-chave

BCL-2 apoptosis; SCLC; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoscience Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google